A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy

Fertility and Sterility

Volumn 76, Issue 5, 2001, Pages 969-973

  Varila, Eero ^a,b   Wahlström, Torsten ^a,c   Rauramo, Ilkka ^a,d  

^a Tampere Health Center   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Oy Leiras Finland Ab   (Finland)

Author keywords

Continuous combined hormone replacement therapy; HRT; Intrauterine system; Levonorgestrel

Indexed keywords

ESTRADIOL; ESTROGEN; LEVONORGESTREL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; FOLLOW UP; HISTOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; MENSTRUATION; POSTMENOPAUSE; PRIORITY JOURNAL;

COHORT STUDIES; DEVICE REMOVAL; DRUG DELIVERY SYSTEMS; DRUG THERAPY, COMBINATION; ENDOMETRIUM; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MEDICAL RECORDS; MIDDLE AGED; PROGESTERONE CONGENERS; PROSPECTIVE STUDIES; UTERINE HEMORRHAGE;

EID: 0034766176     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)02846-1     Document Type: Article

References (17)

1. Henderson BE, Ross RK, Paganini-Hill A, Mack TM. Oestrogen use and cardiovascular disease. Am J Obstet Gynecol 1986;154:1181-6.
2. Marslew U, Overgaard K, Riis BJ, Christiansen C. The new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Obstet Gynecol 1992:79:202-10.
3. Prelevic GM, Jacobs HS. New developments in postmenopausal hormone replacement therapy. Curr Opin Obstet Gynecol 1997;9:207-12.
4. Staland B. Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. Maturitas 1981;3: 145-56.
5. Udoff L, Langenberg P, Adashi E. Combined continuous hormone replacement therapy: a critical review. Obstet Gynecol 1995;86:306-16.
6. Whitehead M. Treatments for menopausal and postmenopausal problems: present and future. Bailliere's Clin Obst 1996;10:515-30.
7. Andersson K, Mattsson LA, Rybo G, Stadberg E. Intrauterine release of levonorgestrel - a new way of adding progestogen in hormone replacement therapy. Obstet Gynecol 1992;79:963-7.
8. Silverberg SG, Haukkamaa M, Arko H, Nilsson CG, Luukkainen T. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. Int J Gynecol Pathol 1986;5:235-41.
9. Raudaskoski T, Lahti E, Kauppila A, Apaja-Sarkkinen M, Laatikainen T. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses. Am J Obstet Gynecol 1995;172:114-9.
10. Suhonen S, Holmström T, Allonen H, Lähteenmäki P. Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy. Fertil Steril 1995;63:336-42.
11. Suhonen S, Holmström T, Lähteenmäki P. Three-year follow-up of the use of a levonorgestrel-releasing intrauterine system in hormone replacement therapy. Acta Obstet Gynecol Scand 1997;76:145-50.
12. Suvanto-Luukkonen E, Sundström H, Penttinen J, Läärä E, Pramila S, Kauppila A. Percutaneous estradiol gel with an intrauterine levonorgestrel releasing device or natural progesterone in hormone replacement therapy. Maturitas 1997;26:211-7.
13. Suvanto-Luukkonen E, Kauppila A. The levonorgestrel intrauterine system in menopausal hormone replacement therapy: five year experience. Fertil Steril 1999;72:161-3.
14. Riphagen F. Intrauterine application of progestins in hormone replacement therapy: a review. Climacteric 2000;3:199-211.
15. Nilsson C, Haukkamaa M, Vierola H, Luukkainen T. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin Endocrinol (Oxf) 1982;17:529-36.
16. Samsioe G. Hormone replacement therapy and vaginal bleeds. Theoretical aspects and clinical management. Zentralbl Gynakol 1996;118: 181-7.
17. Rönnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999;78: 716-21.